Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Director/PDMR Shareholding

9 Nov 2022 15:33

RNS Number : 8784F
Aston Martin Lagonda Glob.Hldgs PLC
09 November 2022
 

9 November 2022

Aston Martin Lagonda Global Holdings plc

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

Aston Martin Lagonda Global Holdings plc (the "Company") announces the following changes in the interests of Directors in the Ordinary Shares in the Company ("Shares"), which took place on 8 November 2022.

Buy-out Share Award

On 8 November 2022, Doug Lafferty (Chief Financial Officer) was granted 659,113 Shares for nil-consideration, the "Buy-out Share Award".

The Buy-out Share Award vested immediately and was settled partly with 349,329 Shares and partly with cash (with the cash element being paid to HMRC to satisfy the income tax and National Insurance due on the award).

Doug is required to retain at least 75% of the 349,329 Shares he received, in accordance with the Company's Executive Directors' shareholding guidelines.

In order to secure Mr Lafferty's appointment and to allow him to join the Company at the earliest opportunity (and as disclosed both on appointment and in the 2021 Directors' Remuneration Report), the Remuneration Committee agreed to buy out awards that Doug forfeited on leaving his previous employer. This buy-out share award compensates Doug for an LTIP award at his previous employer which he forfeited by joining Aston Martin. This Buy-out Share Award was structured to reflect the actual outcome (determined by the previous employer) of the forfeited LTIP award and will be disclosed in full in the 2022 Directors' Remuneration Report.

The Buy-out Share Award is subject to clawback provisions and Doug will be required to repay the award if he resigns or his employment is terminated for cause within 12 months of the award date.

 

 

 

Enquiries:

 

Investors and Analysts

Sherief Bakr,

Director of Investor Relations

 

 

+44 (0)7789 177547

sherief.bakr@astonmartin.com

Media

Kevin Watters,

Director of Communications

 

 

 +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie,

Corporate Communications Manager

 

 +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington

 

+44 (0)20 73534200

 

 

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Doug Lafferty

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares

 

(ISIN: GB00BN7CG237)

b)

Nature of the transaction

Grant of Buy-out Award

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0

659,113

d)

Aggregated information- Aggregated volume

- Price

659,113

£0

e)

Date of the transaction

8 November 2022

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary Shares

 

(ISIN: GB00BN7CG237)

b)

Nature of the transaction

Vesting of Buy-out Award - settled partly by way of Ordinary Shares and partly in cash

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0

349,329

d)

Aggregated information- Aggregated volume

- Price

349,329

£0

e)

Date of the transaction

8 November 2022

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDBBXGDGDC
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.